The University of Chicago Header Logo

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Hariprasad, Seenu
Item TypeName
Concept Receptors, Vascular Endothelial Growth Factor
Concept Vascular Endothelial Growth Factor A
Academic Article A phase I study of intravitreal vascular endothelial growth factor trap-eye in patients with neovascular age-related macular degeneration.
Academic Article Evaluation of very high- and very low-dose intravitreal aflibercept in patients with neovascular age-related macular degeneration.
Academic Article Current concepts in managing wet AMD suboptimally responsive to anti-VEGF therapy.
Academic Article Combination therapy for macular edema secondary to retinal vein occlusion.
Academic Article Comparing aflibercept, bevacizumab, and ranibizumab for DME: analysis of DRCR Protocol T.
Academic Article Current Management of Polypoidal Choroidal Vasculopathy.
Academic Article Effect of Fluid Status at Week 12 on Visual and Anatomic Outcomes at Week 52 in the VIEW 1 and 2 Trials.
Academic Article DRCR Protocol-T: Reconciling 1- and 2-Year Data for Managing Diabetic Macular Edema.
Academic Article Treatments for Diabetic Macular Edema: Past, Present, and Future.
Academic Article Long-term effect of anti-vascular endothelial growth factor injections on intraocular pressure.
Academic Article Treatment Burden in Neovascular AMD:Visual Acuity Outcomes are Associated With Anti-VEGF Injection Frequency.
Academic Article Innovation in Neovascular Age-Related Macular Degeneration: Consideration of Brolucizumab, Abicipar, and the Port Delivery System.
Academic Article Dexamethasone and Anti-VEGF Combination Therapy for the Treatment of Diabetic Macular Edema.
Academic Article Current and upcoming anti-VEGF therapies and dosing strategies for the treatment of neovascular AMD: a comparative review.
Academic Article Abicipar pegol for neovascular age-related macular degeneration.
Academic Article Brolucizumab for persistent macular fluid in neovascular age-related macular degeneration after prior anti-VEGF treatments.
Academic Article Review on the Safety and Efficacy of Brolucizumab for Neovascular Age-Related Macular Degeneration From Major Studies and Real-World Data.
Search Criteria
  • Vascular Endothelial Growth Factor C